Provepharma

Provepharma is a French independent pharmaceutical group that specializes in the revitalization of known pharmaceutical molecules to meet unmet medical needs. The company focuses on developing, manufacturing, and commercializing high-quality active pharmaceutical ingredients (APIs) and finished drug products, particularly for hospital use and critical care. Its portfolio includes Provayblue (methylene blue) for the treatment of acquired methemoglobinemia and Bludigo (indigocarmine) for ureteral visualization during surgery. Provepharma operates with a vertically integrated model, managing the entire value chain from chemical synthesis to international distribution.